# Induction of Labor in Term Pregnancies With Unfavourable Cervix

> **NCT04280874** · PHASE4 · COMPLETED · sponsor: **Clinical Hospital Merkur** · enrollment: 212 (actual)

## Conditions studied

- Induction of Labor Affected Fetus / Newborn
- Prostaglandins Causing Adverse Effects in Therapeutic Use

## Interventions

- **DRUG:** Dinoprostone 0.5 MG
- **DRUG:** Dinoprostone 2 MG/2.5 ML Vaginal Gel/Jelly

## Key facts

- **NCT ID:** NCT04280874
- **Lead sponsor:** Clinical Hospital Merkur
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-10
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04280874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04280874, "Induction of Labor in Term Pregnancies With Unfavourable Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04280874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*